Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Highlights

A collection of news and information related to Johnson & Johnson Inc. published by this site and its partners.

Sort By: Relevancy | Date | Type
Displaying items 1-12 of 178
» View ky3.com items only
    May 25, 2012 |Story| Reuters
  1. UE quiere nuevas guías para anticoagulante Pradaxa de Boehringer

    Reuters
    LONDRES, 25 mayo (Reuters) - Médicos y pacientes deberían recibir guías más claras sobre cómo evitar los riesgos de hemorragia al usar el nuevo medicamento Pradaxa, de Boehringer Ingelheim, para prevenir accidentes cerebrovasculares, indicaron el...

    Tags: Pradaxa (drug), Drugs and Medicines, Xarelto (drug), Health, Bristol Myers Squibb Company

  2. May 25, 2012 |Story| Reuters
  3. EU mergers and takeovers (May 25)

    Reuters
    BRUSSELS, May 25 (Reuters) - The following are mergers under review by the European Commission and a brief guide to the EU merger process: APPROVALS AND WITHDRAWALS -- British packaging company DS Smith to acquire the recyclyed packaging operations...

    Tags: Germany, United Kingdom, Business Enterprises, Citigroup Incorporated, Car Engine Repair

  4. May 25, 2012 |Story| Reuters
  5. Reuters Health News Summary

    Reuters
    Following is a summary of current health news briefs. Obesity not always tied to higher heart risk: study NEW YORK (Reuters Health) - An obese person isn't inevitably at increased risk of cardiovascular disease and death, a new U.K. study finds. ``The...

    Tags: Hospira, Inc., Roche Holding AG, Patents, Copyrights and Trademarks, Obesity, Religion and Belief

  6. May 25, 2012 |Story| Reuters
  7. EU body wants new guidance on Boehringer clot drug

    Reuters
    LONDON, May 25 (Reuters) - Doctors and patients should be given clearer guidance on how to avoid bleeding risks when using Boehringer Ingelheim's new stroke prevention pill Pradaxa, European regulators said on Friday. The European Medicines Agency said...

    Tags: Pradaxa (drug), Cardiac Arrhythmia, Warfarin (drug), Xarelto (drug), Europe

  8. May 24, 2012 |Story| Reuters
  9. UPDATE 1-U.S. Senate passes bipartisan FDA funding bill

    Reuters
    * Authorizes industry fees that help fund FDA * Senate voted 96-1 in favor of bill * Includes new law to prevent drug shortages By Anna Yukhananov WASHINGTON, May 24 (Reuters) - The U.S. Senate on Thursday showed near-unanimous support for a bill that...

    Tags: Amy Klobuchar, Politics, Roche Holding AG, Consumers, Lobbying

  10. May 24, 2012 |Story| Reuters
  11. U.S. Senate passes bipartisan FDA funding bill

    Reuters
    WASHINGTON (Reuters) - The U.S. Senate on Thursday showed near-unanimous support for a bill that helps fund the U.S. Food and Drug Administration, a regulatory powerhouse with sweeping influence over the foods Americans eat and the medicines they take....

    Tags: Amy Klobuchar, Politics, Roche Holding AG, Consumers, Lobbying

  12. May 24, 2012 |Story| Reuters
  13. How to play it - A debt ceiling sequel?

    Reuters
    NEW YORK (Reuters) - Another showdown between Republicans in Congress and President Barack Obama over debt could be in the making, and some investors are already taking steps to prepare for it. While most of the market was focused on Europe's debt crisis...

    Tags: John A. Boehner, Congressional Budget Office, Christopher Van Hollen Jr., Merck & Company Incorporated, U.S. House Committee on the Budget

  14. May 23, 2012 |Story| Reuters
  15. U.S. advisers reject J&J/Bayer's Xarelto for acute coronary patients

    Reuters
    SILVER SPRING, Maryland (Reuters) - U.S. advisers recommended against expanding the use of Johnson & Johnson's blood thinner Xarelto as a way to reduce the risk of new heart attacks and strokes in people with heart problems. A panel of outside experts to...

    Tags: Cardiac Arrhythmia, Hospitals and Clinics, Trials, Cleveland Clinic, Blood

  16. May 23, 2012 |Story| Reuters
  17. UPDATE 1-US advisers reject new use for J&J/Bayer's Xarelto

    Reuters
    SILVER SPRING, Md., May 23 (Reuters) - U.S. advisers recommended against expanding the use of Johnson & Johnson's blood thinner Xarelto as a way to reduce the risk of new heart attacks and strokes in people with heart problems. A panel of outside experts...

    Tags: Hospitals and Clinics, Cleveland Clinic, Heart Problems, Heart Attack, Aspirin (drug)

  18. May 23, 2012 |Story| Reuters
  19. HOW TO PLAY IT - A debt ceiling sequel?

    Reuters
    By David K. Randall NEW YORK, May 23 (Reuters) - Another showdown between Republicans in Congress and President Barack Obama over debt could be in the making, and some investors are already taking steps to prepare for it. While most of the market was...

    Tags: John A. Boehner, Christopher Van Hollen Jr., Merck & Company Incorporated, Barack Obama, Google Inc.

  20. May 23, 2012 |Story| Reuters
  21. UPDATE 2-US advisers reject new use for J&J/Bayer's Xarelto

    Reuters
    * Xarelto already approved for two other uses * FDA advisers concerned about missing data, bleeding risks * FDA to make a final decision by end of June By Anna Yukhananov SILVER SPRING, Md., May 23 (Reuters) - U.S. advisers recommended against...

    Tags: Hospitals and Clinics, Cardiac Arrhythmia, Trials, Cleveland Clinic, Heart Problems

  22. May 23, 2012 |Story| Reuters
  23. J&J, Amazon on list that hedge funds love to hate

    Reuters
    By Svea Herbst-Bayliss BOSTON, May 23 (Reuters) - Hedge funds turned their backs on Johnson & Johnson and Amazon.com Inc in the last months, kicking the former market darlings into a group where they see stock prices dropping, research from Goldman Sachs...

    Tags: David Einhorn, Moody's Corporation, Berkshire Hathaway Incorporated, S&P 500, Stock Market

 1  2 3 4 5 6 7 8 9 10 11-15Next >
Original site for Johnson & Johnson Inc. topic gallery.
Loading...
 
 

Date:

Credit:

User-submitted

Tags:

Rate:
Sending...

E-mail this photo

Error: malformed email address(es)
Both "from" and "recipient" email fields are required.

Recipient E-mail Addresses

(up to 3, separated by commas) Send me a copy.

From:

e-mail | buy this photo | link to photo
Johnson & Johnson Inc. Photos
* New Brunswick, N.J. * Category: Pharmaceutical, medic...
(May 4, 2012)
9. Johnson & Johnson
With better-than-expected first-quarter earnings, Goldm...
(April 17, 2012)
Goldman Sachs, Johnson & Johnson, Coca Cola report strong earnings. Mattel disappoints
VanderMolen is a specialist in corporate communications...
(March 13, 2012)
Alan VanderMolen, vice chairman, Daniel J. Edelman